Morgan Stanley’s EnteroMedics Inc. ETRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-1,564
| Closed | -$3K | – | 6923 |
|
|
2017
Q3 | $3K | Buy |
1,564
+453
| +41% | +$1.33K | ﹤0.01% | 6394 |
|
|
2017
Q2 | $5K | Sell |
1,111
-45,179
| -98% | -$225K | ﹤0.01% | 6370 |
|
|
2017
Q1 | $267K | Buy |
46,290
+46,151
| +33,202% | +$341K | ﹤0.01% | 5177 |
|
|
2016
Q4 | $0 | Buy |
139
+134
| +2,680% | +$703 | ﹤0.01% | 6758 |
|
|
2016
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 6789 |
|
|
2016
Q2 | $0 | Buy |
5
+3
| +150% | +$137 | ﹤0.01% | 7030 |
|
|
2016
Q1 | $0 | Sell |
2
-337
| -99% | -$27.2K | ﹤0.01% | 7074 |
|
|
2015
Q4 | $46K | Sell |
339
-330
| -49% | -$68.4K | ﹤0.01% | 5757 |
|
|
2015
Q3 | $182K | Buy |
669
+657
| +5,475% | +$210K | ﹤0.01% | 5130 |
|
|
2015
Q2 | $8K | Sell |
12
-1
| -8% | -$1.15K | ﹤0.01% | 6359 |
|
|
2015
Q1 | $13K | Buy |
13
+3
| +30% | +$3.62K | ﹤0.01% | 6177 |
|
|
2014
Q4 | $15K | Sell |
10
-45
| -82% | -$60.8K | ﹤0.01% | 6136 |
|
|
2014
Q3 | $71K | Sell |
55
-4
| -7% | -$5.86K | ﹤0.01% | 5613 |
|
|
2014
Q2 | $97K | Buy |
59
+49
| +490% | +$91.6K | ﹤0.01% | 5516 |
|
|
2014
Q1 | $19K | Buy |
10
+1
| +11% | +$2.37K | ﹤0.01% | 5985 |
|
|
2013
Q4 | $20K | Sell |
9
-3
| -25% | -$4.83K | ﹤0.01% | 5876 |
|
|
2013
Q3 | $16K | Sell |
12
-54
| -82% | -$62.8K | ﹤0.01% | 5293 |
|
|
2013
Q2 | $80K | Buy |
+66
| New | +$69.7K | ﹤0.01% | 5126 |
|
Other funds holding ETRM
Morgan Stanley's ETRM Position: Q4 2017 in Review
Morgan Stanley sold out of EnteroMedics Inc. (ETRM) in Q4 2017, closing a stake of 1,564 shares — an estimated $3K sold.
Morgan Stanley first reported a position in ETRM in Q2 2013 and held it in 18 quarters. The position peaked at $267K in Q1 2017. 1 fund tracked by Wall St. Rank holds ETRM as of Q4 2017.
- Morgan Stanley reported no remaining EnteroMedics Inc. position as of Q4 2017 after selling out during the quarter.
- Morgan Stanley sold 1,564 EnteroMedics Inc. shares in Q4 2017, an estimated $3K.
- Morgan Stanley first reported a position in EnteroMedics Inc. in Q2 2013 and held it in 18 quarters.
- Morgan Stanley's EnteroMedics Inc. position peaked at $267K in Q1 2017.
- 1 fund tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2017.
Based on Morgan Stanley's 13F filing for Q4 2017, filed 14 Feb 2018.